Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
J Struct Funct Genomics ; 17(2-3): 39-49, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27400687

ABSTRACT

We present a new method for predicting protein-ligand-binding sites based on protein three-dimensional structure and amino acid conservation. This method involves calculation of the van der Waals interaction energy between a protein and many probes placed on the protein surface and subsequent clustering of the probes with low interaction energies to identify the most energetically favorable locus. In addition, it uses amino acid conservation among homologous proteins. Ligand-binding sites were predicted by combining the interaction energy and the amino acid conservation score. The performance of our prediction method was evaluated using a non-redundant dataset of 348 ligand-bound and ligand-unbound protein structure pairs, constructed by filtering entries in a ligand-binding site structure database, LigASite. Ligand-bound structure prediction (bound prediction) indicated that 74.0 % of predicted ligand-binding sites overlapped with real ligand-binding sites by over 25 % of their volume. Ligand-unbound structure prediction (unbound prediction) indicated that 73.9 % of predicted ligand-binding residues overlapped with real ligand-binding residues. The amino acid conservation score improved the average prediction accuracy by 17.0 and 17.6 points for the bound and unbound predictions, respectively. These results demonstrate the effectiveness of the combined use of the interaction energy and amino acid conservation in the ligand-binding site prediction.


Subject(s)
Databases, Protein , Models, Molecular , Software , Streptavidin , Binding Sites , Sequence Analysis, Protein , Streptavidin/chemistry , Streptavidin/genetics
2.
Sci Rep ; 5: 16747, 2015 Nov 18.
Article in English | MEDLINE | ID: mdl-26576490

ABSTRACT

Changes of intracellular and extracellular pH are involved in a variety of physiological and pathological processes, in which regulation of the Ca(2+) release activated Ca(2+) channel (I CRAC) by pH has been implicated. Ca(2+) entry mediated by I CRAC has been shown to be regulated by acidic or alkaline pH. Whereas several amino acid residues have been shown to contribute to extracellular pH (pHo) sensitivity, the molecular mechanism for intracellular pH (pHi) sensitivity of Orai1/STIM1 is not fully understood. By investigating a series of mutations, we find that the previously identified residue E106 is responsible for pHo sensitivity when Ca(2+) is the charge carrier. Unexpectedly, we identify that the residue E190 is responsible for pHo sensitivity when Na(+) is the charge carrier. Furthermore, the intracellular mutant H155F markedly diminishes the response to acidic and alkaline pHi, suggesting that H155 is responsible for pHi sensitivity of Orai1/STIM1. Our results indicate that, whereas H155 is the intracellular pH sensor of Orai1/STIM1, the molecular mechanism of external pH sensitivity varies depending on the permeant cations. As changes of pH are involved in various physiological/pathological functions, Orai/STIM channels may be an important mediator for various physiological and pathological processes associated with acidosis and alkalinization.


Subject(s)
Amino Acid Motifs , Amino Acids , Calcium Channels/chemistry , Calcium Channels/metabolism , Hydrogen-Ion Concentration , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Neoplasm Proteins/chemistry , Neoplasm Proteins/metabolism , Calcium/metabolism , Calcium Channels/genetics , Extracellular Space/metabolism , HEK293 Cells , Humans , Intracellular Space/metabolism , Membrane Potentials , Membrane Proteins/genetics , Mutation , Neoplasm Proteins/genetics , ORAI1 Protein , Protons , Stromal Interaction Molecule 1
3.
Circ Res ; 106(5): 992-1003, 2010 Mar 19.
Article in English | MEDLINE | ID: mdl-20075334

ABSTRACT

RATIONALE: Cardiac fibrosis contributes to pathogenesis of atrial fibrillation (AF), which is the most commonly sustained arrhythmia and a major cause of morbidity and mortality. Although it has been suggested that Ca(2+) signals are involved in fibrosis promotion, the molecular basis of Ca(2+) signaling mechanisms and how Ca(2+) signals contribute to fibrogenesis remain unknown. OBJECTIVE: To determine the molecular mechanisms of Ca(2+)-permeable channel(s) in human atrial fibroblasts, and to investigate how Ca(2+) signals contribute to fibrogenesis in human AF. METHODS AND RESULTS: We demonstrate that the transient receptor potential (TRP) melastatin related 7 (TRPM7) is the molecular basis of the major Ca(2+)-permeable channel in human atrial fibroblasts. Endogenous TRPM7 currents in atrial fibroblasts resemble the biophysical and pharmacological properties of heterologous expressed TRPM7. Knocking down TRPM7 by small hairpin RNA largely eliminates TRPM7 current and Ca(2+) influx in atrial fibroblasts. More importantly, atrial fibroblasts from AF patients show a striking upregulation of both TRPM7 currents and Ca(2+) influx and are more prone to myofibroblast differentiation, presumably attributable to the enhanced expression of TRPM7. TRPM7 small hairpin RNA markedly reduced basal AF fibroblast differentiation. Transforming growth factor (TGF)-beta1, the major stimulator of atrial fibrosis, requires TRPM7-mediated Ca(2+) signal for its effect on fibroblast proliferation and differentiation. Furthermore, TGF-beta1-induced differentiation of cultured human atrial fibroblasts is well correlated with an increase of TRPM7 expression induced by TGF-beta1. CONCLUSIONS: Our results establish that TRPM7 is the major Ca(2+)-permeable channel in human atrial fibroblasts and likely plays an essential role in TGF-beta1-elicited fibrogenesis in human AF.


Subject(s)
Atrial Fibrillation/metabolism , Calcium Signaling , Fibroblasts/metabolism , TRPM Cation Channels/metabolism , Aged , Aged, 80 and over , Animals , Atrial Fibrillation/pathology , Cell Differentiation , Cell Membrane Permeability , Cell Proliferation , Female , Fibroblasts/pathology , Fibrosis , Heart Atria/metabolism , Heart Atria/pathology , Humans , Male , Membrane Potentials , Mice , Protein Serine-Threonine Kinases , RNA Interference , TRPM Cation Channels/genetics , Transforming Growth Factor beta1/metabolism , Up-Regulation
4.
Am J Physiol Heart Circ Physiol ; 294(1): H285-92, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17982015

ABSTRACT

Cholesterol is a primary constituent of the plasmalemma, including the lipid rafts/caveolae, where various G protein-coupled receptors colocalize with signaling proteins and channels. By manipulating cholesterol in rabbit and rat ventricular myocytes using methyl-beta-cyclodextrin (MbetaCD), we studied the role of cholesterol in the modulation of L-type Ca(2+) currents (I(Ca,L)). MbetaCD was mainly dialyzed from BAPTA-containing pipette solution during whole cell clamp. In rabbit myocytes dialyzed with 30 mM MbetaCD for 10 min, a positive shift in membrane potential at half-maximal activation (V(0.5)) from -8 to -2 mV developed and was associated with an increase in current density at positive potentials (42% at +20 mV vs. time-matched controls). Isoproterenol (ISO) increased I(Ca,L) approximately threefold and caused a negative shift in V(0.5) in control cells, but it did not increase I(Ca,L) in MbetaCD-treated myocytes, nor did it shift V(0.5). The effect of MbetaCD (10 or 30 mM) was concentration dependent: 30 mM MbetaCD suppressed the ISO-induced increase in I(Ca,L) more effectively than 10 mM MbetaCD. MbetaCD dialysis also abolished the increase in I(Ca,L) elicited by forskolin or dibutyryl cAMP, but not that elicited by (-)BAY K 8644. External application of MbetaCD-cholesterol complex to rat myocytes attenuated the MbetaCD-mediated inhibition of the ISO-induced increase of I(Ca,L). Biochemical analysis confirmed that the myocytes' cholesterol content was diminished by MbetaCD and increased by MbetaCD-cholesterol complex. Cholesterol thus appears to contribute to the regulation of basal I(Ca,L) and beta-adrenergic cAMP/PKA-mediated increases in I(Ca,L). We suggest that cholesterol affects the structural coupling between L-type Ca(2+) channels and adjacent regulatory proteins.


Subject(s)
Calcium Channels, L-Type/metabolism , Calcium Signaling , Cholesterol/deficiency , Membrane Microdomains/metabolism , Myocytes, Cardiac/metabolism , Receptors, Adrenergic, beta/metabolism , 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology , Adenylyl Cyclases/metabolism , Adrenergic beta-Agonists/pharmacology , Animals , Calcium Channel Agonists/pharmacology , Calcium Channels, L-Type/drug effects , Calcium Signaling/drug effects , Colforsin/pharmacology , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic CMP/analogs & derivatives , Cyclic CMP/pharmacology , Dose-Response Relationship, Drug , Enzyme Activators/pharmacology , Heart Ventricles/metabolism , In Vitro Techniques , Isoproterenol/pharmacology , Membrane Microdomains/drug effects , Membrane Potentials , Myocytes, Cardiac/drug effects , Rabbits , Rats , Rats, Wistar , Receptors, Adrenergic, beta/drug effects , Time Factors , beta-Cyclodextrins/pharmacology
5.
Masui ; 56(4): 386-94, 2007 Apr.
Article in Japanese | MEDLINE | ID: mdl-17441444

ABSTRACT

BACKGROUND: We compared the effects of nitrous oxide (N2O) plus isoflurane with equianesthetic isoflurane alone on the L-type calcium current (I(Ca,L)), and also investigated their modulation of beta-adrenoceptor stimulation. METHODS: I(Ca,L) was recorded from enzymatically isolated rabbit ventricular myocytes using the whole-cell patch clamp technique. Ventricular myocytes were exposed to prepluses of -40 mV from a holding potential of -80 mV and then to +50 mV in 10 mV increments and thereafter the depolarization pulses that acquire peak currents were applied every 10 seconds. The changes in I(Ca,L) were measured in exposure to experimental gases of 1 MAC:1) 0.5% isoflurane and N2O:O2 (2:1) (I-N20) and 2) 1.15% isoflurane and N2:O2,(2:1) (I-N2). RESULTS: I-N2O and I-N2 depressed the peak I(Ca,L) by 15.6 +/- 9.2 and 14.6 +/- 8.1%, respectively. In the presence of 1 microM isoproterenol or 10 microM forskolin, the depression by I-N20 was significantly suppressed, but not by I-N2. CONCLUSIONS: The results show that I-N2O and I-N2 depressed I(Ca,L) to a similar degree without beta-adrenoceptor stimulation. The depression by I-N2O, however, was modulated by beta-adrenoceptor stimulation. Beta-adrenoceptor stimulation was thus found to modulate the effect of N2O combined with isoflurane rather than equianesthetic isoflurane alone.


Subject(s)
Anesthetics/pharmacology , Calcium Channels, L-Type/drug effects , Isoflurane/pharmacology , Myocytes, Cardiac/drug effects , Nitrous Oxide/pharmacology , Receptors, Adrenergic, beta/drug effects , Animals , Cells, Cultured , Colforsin/pharmacology , Drug Combinations , Heart Ventricles/cytology , Isoproterenol/pharmacology , Patch-Clamp Techniques , Rabbits
6.
Pflugers Arch ; 446(6): 695-701, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12827360

ABSTRACT

Although often used as a Ca(2+) channel blocker, Mn(2+), in fact, permeates through Ca(2+) channels. Under Na(+)-free conditions, depolarizing pulses evoked slowly-decaying Mn(2+) currents ( I(Mn)). Maximal I(Mn) densities in the presence of 5 and 20 mM Mn(2+) were 0.42+/-0.12 pA/pF (mean+/-SEM, n=17) and 1.23+/-0.10 pA/pF ( n=40), respectively. At 5 mM, the ratio of maximal amplitude of I(Mn) to that of the Ca(2+) current ( I(Ca)) was 0.079+/-0.009 ( n=8). I(Mn) elicited from a holding potential of -50 mV was depressed by nitrendipine (1 microM) by approximately 70%. Nitrendipine (0.3 microM) shifted the steady-state inactivation curve to more negative potentials and shifted the potential for half-maximal inactivation ( E(0.5)) from 1.3 to -8.8 mV and also decreased the time constant of decay of I(Mn) at 20 mV from 986.2 to 167.9 ms. BAY K 8644 (1 microM), isoproterenol (10 microM) and forskolin (10 microM) all increased I(Mn) and shifted the current/voltage ( I/ V) relationship to more negative potentials. The small, slowly-inactivating I(Mn) is thus modulated by dihydropyridine Ca(2+) channel modulators and cyclic AMP-mediated phosphorylation in a manner similar to other L-type Ca(2+) channel currents. L-type Ca(2+) channels are involved in the regulation of intracellular [Mn] in ventricular myocytes.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Calcium Channel Blockers/pharmacology , Colforsin/pharmacology , Dihydropyridines/pharmacology , Ion Channels/metabolism , Isoproterenol/pharmacology , Manganese/metabolism , Myocardium/metabolism , Myocytes, Cardiac/metabolism , 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology , Animals , Calcium Channel Agonists/pharmacology , Cyclic AMP/physiology , Electrophysiology , Heart Ventricles/cytology , Heart Ventricles/drug effects , Heart Ventricles/metabolism , In Vitro Techniques , Ion Channel Gating/drug effects , Ion Channels/drug effects , Membrane Potentials/physiology , Myocardium/cytology , Myocytes, Cardiac/drug effects , Nitrendipine/pharmacology , Patch-Clamp Techniques , Rabbits , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL